Leucovorin, a drug for chemo side effects, may aid speech in nonverbal autistic children by allowing folic acid into the ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.

Mason Connor, a 5-year-old with nonverbal autism disorder, spoke his first words just three days after taking the inexpensive ...

Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for survival in patients with resectable esophageal squamous cell carcinoma (JCOG2305A). This is an ...

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Pfizer has announced that its Braftovi (encorafenib) regimen significantly improved both progression-free and overall survival in a late-stage colorectal cancer (CRC) study.

leucovorin and oxaliplatin) for metastatic colorectal cancer (mCRC) harboring a BRAF V600E mutation. Pfizer shares fell 1.2% to close at $26.20 on Monday. Benzinga readers can access the latest ...

leucovorin, and oxaliplatin) in patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation. At the time of this analysis, the Braftovi combination regimen demonstrated a ...